HIV CareLink Newsletter
HIV CareLink Newsletter
The HIV CareLink Newsletter is sent by email to HIV care providers. The newsletter provides summaries of the latest treatment guideline updates from the Department of Health and Human Services (DHHS) and other clinical practice updates pertaining to HIV/AIDS and related conditions. The newsletter includes information on training opportunities in the region, and other useful information. Special announcements with urgent clinical information such as notices of updated treatment guidelines, new drug approvals and drug label updates are issued as necessary.
2013
2012
2011
2010
2009
2008
June 18, 2013
SPECIAL ANNOUNCEMENT: Corrections to the Adult and Adolescent OI Prevention and Treatment Guidelines Issued
May 8, 2013
SPECIAL ANNOUNCEMENT: Department of Health and Human Services (DHHS) Releases Updates to the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Guidelines
April 5, 2013
SPECIAL ANNOUNCEMENT: Meningococcal Vaccine Recommendation Expanded to MSM who have Traveled to NYC
March 29, 2013
Update: Guidelines for the Use of Antiretroviral Agents in
HIV-1-Infected Adults and Adolescents
February 13, 2013
SPECIAL ANNOUNCEMENT: HIV/AIDS Update-Recent Changes to
Reyataz (atazanavir sulfate) Capsule Labeling
February 13, 2013
SPECIAL ANNOUNCEMENT: Department of Health and Human Services (DHHS) Releases Updates to Adult
and Adolescent Antiretroviral Treatment Guidelines
February 11, 2013
SPECIAL ANNOUNCEMENT: FDA approves revisions to Prezista (darunavir) label to include once daily dosing
December 11, 2012
SPECIAL ANNOUNCEMENT: FDA approves labeling updates for Edurant (rilpivirine)
December 6, 2012
Update: Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
November 19, 2012
SPECIAL ANNOUNCEMENT: Federal Drug Administration (FDA) approves Prezista®(darunavir) 800 mg strength tablet
November 8, 2012
SPECIAL ANNOUNCEMENT: Department of Health and Human Services (DHHS) released updates to Guidelines for the Use of Antiretroviral Agents (ARVs) in Pediatric HIV Infection
September 24, 2012
SPECIAL ANNOUNCEMENT: Department of Health and Human Services (DHHS) Panel Recommends Stribild™ as Alternative First-line Regimen
August 29, 2012
SPECIAL ANNOUNCEMENT: FDA approves new fixed-dose combination pill to treat HIV in some patients.
August 9, 2012
SPECIAL ANNOUNCEMENT: Department of Health and Human Services (DHHS) Releases Updates to Perinatal Guidelines.
August 9, 2012
SPECIAL ANNOUNCEMENT: International AIDS Society Recommends Treatment for all HIV Patients.
July 18, 2012
SPECIAL ANNOUNCEMENT: FDA approves Truvada® as PrEP to reduce risk of HIV infection in uninfected individuals.
May 9, 2012
SPECIAL ANNOUNCEMENT: New pediatric dosing approved for ritonavir-boosted LEXIVA® (fosamprenavir), in combination with other antiretroviral drugs.
April 13, 2012
Updated Adult/Adolescent Department of Health and Human Services (DHHS) Antiretroviral Guidelines
March 30, 2012
SPECIAL ANNOUNCEMENT: Pediatric approval for INTELENCE® and DHHS Adult/Adolescent Guidelines update
January 9, 2012
SPECIAL ANNOUNCEMENT: FDA approves revisions to Sustiva (efavirenz) package insert for Dosing and Administration and Drug Interaction sections
December 22, 2011
SPECIAL ANNOUNCEMENT: FDA approved pediatric dosing recommendations for Isentress.
December 20, 2011
SPECIAL ANNOUNCEMENT: FDA approved on Dec. 16, 2011, an oral suspension formulation of Prezista.
December 9, 2011
SPECIAL ANNOUNCEMENT: FDA has issued safety revisions to Norvir tablets, capsules and oral solution product labeling.
November 7, 2011
SPECIAL ANNOUNCEMENT: FDA has issued updates for the Isentress (raltegravir) package insert
October 20, 2011
Updated Adult/Adolescent Department of Health and Human Services (DHHS) Antiretroviral Guidelines Released October 14, 2011
September 22, 2011
Update: Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the U.S.
September 7, 2011
Prevention of Mother-to-Child transmission of HIV: Review and New Perspectives
August 25, 2011
Special Bulletin: Use of Antiretroviral Agents in Pediatric Infection Guidelines
April 25, 2011
Preexposure Prophylaxis for the Prevention of HIV Infection in Men Who Have Sex with Men Interim Guidance
March 22, 2011
Prevention and Treatment of Opportunistic Infections (OIs) in HIV-Infected Adults and Adolescents Guidelines Summary
December 22, 2010
Recommendations on the use of pneumococcal vaccines in HIV infection
November 30, 2010
Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes
December 2, 2009
Special Bulletin: Updated Adult/Adolescent DHHS Antiretroviral Guidelines
September 1, 2009
• Special Bulletin: Opportunistic Infections (OIs) Guidelines for HIV-Exposed and HIV-Infected Children - Updated
• Safety Alert: Intelence™ (Etravirine)
• Safety Alert: Intelence™ (Etravirine)
August 21, 2009
Update on Immunizations in HIV-Infected and Exposed Children and Adolescents
July 20, 2009
• Special Bulletin: Isentress® (raltegravir) Receives FDA Approval for Treatment-Naïve Patients
• Testing for Rectal and Pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis Infections by Gay-Focused Community-Based Organizations - 5 U.S. Cities, 2007
• Testing for Rectal and Pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis Infections by Gay-Focused Community-Based Organizations - 5 U.S. Cities, 2007
April 29, 2009
Special Bulletin: Swine-origin Influenza A (H1N1) Virus (S-OIV) Infection
April 21, 2009
Conference Update: The 16th Conference on Retroviruses and Opportunistic Infections (CROI 2009) - February 8-11, 2009 - Montreal, Canada
January 13, 2009
Special Bulletin: Recent Updates to Florida Medicaid Formulary That May Affect HIV-infected Patients
January 5, 2009
• Conference Update - 48th Annual ICAAC/IDSA 46th Annual Meeting - October 25-28, 2008 - Washington, DC
• Conference Update - XVII International AIDS Conference August 3-8, 2008 - Mexico City, Mexico
• Conference Update - XVII International AIDS Conference August 3-8, 2008 - Mexico City, Mexico
August 12, 2008
Update on the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
August 1, 2008
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Children
July 8, 2008
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents
June 11, 2008
Update on the 15th Conference on Retroviruses and Opportunistic Infections (CROI): Boston, MA - February 3-6, 2008
April 25, 2008
Update on the 15th Conference on Retroviruses and Opportunistic Infections (CROI): Boston, MA - February 3-6, 2008
March 10, 2008
Special Bulletin: Pediatric Guidelines for Use of Antiretroviral Agents Updated February 28, 2008
January 31, 2008
Special Bulletin: Adult and Adolescent Antiretroviral Guidelines Updated January 29, 2008
Copyright 2000 - 2013 - Florida/Caribbean AIDS Education and Training Center
Funded by the U.S. Public Health Service's Health Resources Service Administration (HRSA)
DHHS-HAB Grant No. H4AHA00049
Disability Statement | Privacy Statement | Usage Guidelines